Director/PDMR Shareholding

RNS Number : 6626Y
GlaxoSmithKline PLC
06 March 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr S A Hussain

b)

Position/status

President, Global Pharmaceuticals

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882 

 

b)

Nature of the transaction

The sale of 98,581.776 Ordinary Shares on 6 March 2017 at a price of £16.8006.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.8006

98,581.776

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2017-03-06

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs S G Hussain

b)

Position/status

PCA of Mr S A Hussain (President, Global Pharmaceuticals)

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

  

b)

Nature of the transaction

The sale of 131,418 Ordinary Shares on 6 March 2017 at a price of £16.835.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£16.835

131,418

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2017-03-06

f)

Place of the transaction

 

London Stock Exchange (XLON)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQQLFBDXFZBBV

Companies

GSK (GSK)
UK 100

Latest directors dealings